| [1] |
Poiesz B,Maytal J,Horowitz S, et al. Progressive nemaline rod myopathy in a woman coinfected with HIV－1 and HTLV－2[J]. Mount Sinai Journal of Medicine New York, 1993, 60(3): 242-246.
|
| [2] |
Carneiroproietti AB,Catalansoares BC,Castrocosta CM, et al. HTLV in the Americas: challenges and perspectives[J]. Revista panamericana de salud publica, 2006, 19(1): 44-53.
|
| [3] |
Sagawa K,Mochizuki M,Masuoka K, et al. Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV－Ⅰ) uveitis. Detection of HTLV－Ⅰ－infected T cells in the eye and their constitutive cytokine production[J]. J Clinical Inves, 1995, 95(2): 852-858.
|
| [4] |
Kase S,Namba K,Kitaichi N, et al. Clinical features of human T lymphotropic virus type 1－associated uveitis in Hokkaido, Japan[J]. Japanese Journal of Ophthalmology, 2013, 57(4): 379-384.
|
| [5] |
Filippone C,Betsem E,Tortevoye P, et al. A Severe Bite From a Nonhuman Primate Is a Major Risk Factor for HTLV－1 Infection in Hunters From Central Africa[J]. Clinical Infectious Diseases, 2015, 60(11): 1667-1676.
|
| [6] |
Rathsam－Pinheiro RH,Boa－Sorte N,Castro－Lima－Vargens C, et al. Ocular lesions in HTLV－1 infected patients from Salvador, State of Bahia: the city with the highest prevalence of this infection in Brazil[J]. Revista Da Sociedade Brasileira De Medicina Tropical, 2009, 42(6): 633-637.
|
| [7] |
Bangham CR. HTLV－1 infections[J]. Journal of Clinical Pathology, 2000, 53(8): 581-586.
|
| [8] |
Koju K,Manabu M. HTLV－1 uveitis[J]. Frontiers in Microbiology, 2012, 3(2): 270-274.
|
| [9] |
Gonçalves DU,Proietti FA,Ribas JGR, et al. Epidemiology, treatment, and prevention of human T－cell leukemia virus type 1－associated diseases[J]. Clinical Microbiology Reviews, 2010, 23(3): 577-589.
|
| [10] |
Satou Y,Matsuoka M. HTLV－1 and the host immune system: how the virus disrupts immune regulation, leading to HTLV－1 associated diseases[J]. Journal of Clinical & Experimental Hematopathology Jceh, 2010, 50(1): 1-8.
|
| [11] |
Olière S,Douville R,Sze A, et al. Modulation of innate immune responses during human T－cell leukemia virus (HTLV－1) pathogenesis[J]. Cytokine & Growth Factor Reviews, 2011, 22(4): 197-210.
|
| [12] |
Furuta RA,Sugiura K,Kawakita S, et al. Mouse Model for the Equilibration Interaction between the Host Immune System and Human T－Cell Leukemia Virus Type 1 Gene Expression[J]. Journal of Virology, 2002, 76(6): 2703-2713.
|
| [13] |
Jacobson S,Shida H,Mcfarlin DE, et al. Circulating CD8＋ cytotoxic T lymphocytes specific for HTLV－Ⅰ pX in patients with HTLV－Ⅰ associated neurological disease.[J]. Nature, 1990, 348(6298): 245-248.
|
| [14] |
Komatsu N,Wang Y,Malissen B, et al. Heterogeneity of Natural Foxp3＋ T Cells: A Committed Regulatory T－Cell Lineage and an Uncommitted Minor Population Retaining Plasticity[J]. Proceedings of the National Academy of Sciences of the United States of America, 2009, 106(6): 1903-1908.
|
| [15] |
Bangham CR,Osame M. Cellular immune response to HTLV－1[J]. Oncogene, 2005, 24(39): 6035-6046.
|
| [16] |
Ono A,Mochizuki M,Yamaguchi K, et al. Increased number of circulating HTLV－1 infected cells in peripheral blood mononuclear cells of HTLV－1 uveitis patients: a quantitative polymerase chain reaction study[J]. Brit J Ophthalmol, 1995, 79(3): 270-276.
|
| [17] |
Mita S,Sugimoto M,Nakamura M, et al. Increased human T lymphotropic virus type－1 (HTLV－1) proviral DNA in peripheral blood mononuclear cells and bronchoalveolar lavage cells from Japanese patients with HTLV－1－associated myelopathy[J]. American Journal of Tropical Medicine & Hygiene, 1993, 48(2): 170-177.
|
| [18] |
Levin MC,Fox RJ,Lehky T, et al. PCR－in situ hybridization detection of human T－cell lymphotropic virus type 1 (HTLV－1) tax proviral DNA in peripheral blood lymphocytes of patients with HTLV－1－associated neurologic disease[J]. Journal of Virology, 1996, 70(2): 924-933.
|
| [19] |
Maruyama M,Shibuya H,Harada H, et al. Evidence for aberrant activation of the interleukin－2 autocrine loop by HTLV－1－encoded p40 x, and T3/Ti complex triggering[J]. Cell, 1987, 48(2): 343-350.
|
| [20] |
Yoshida M,Miyoshi I,Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T－cell leukemia and its implication in the disease[J]. Proceedings of the National Academy of Sciences of the United States of America, 1982, 79(6): 2031-2035.
|
| [21] |
Smith MR,Greene WC. Type Ⅰ human T cell leukemia virus tax protein transforms rat fibroblasts through the cyclic adenosine monophosphate response element binding protein/activating transcription factor pathway[J]. Journal of Clinical Investigation, 1991, 88(3): 1038-1042.
|
| [22] |
Rebouissou S,Imbeaud S,Balabaud C, et al. HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP－1 and carbohydrate－response element－binding protein (ChREBP) activation.[J]. Journal of Biological Chemistry, 2007, 282(19): 14437-14446.
|
| [23] |
Jaroscak J,Goltry K,Smith A, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo－expanded UCB cells: results of a phase 1 trial using the AastromReplicell System.[J]. Blood, 2003, 101(12): 5061-5067.
|
| [24] |
Chan CC,Benezra D,Rodrigues MM, et al. Immunohistochemistry and electron microscopy of choroidal infiltrates and Dalen－Fuchs nodules in sympathetic ophthalmia[J]. Ophthalmology, 1985, 92(4): 580-590.
|
| [25] |
Meeker ND,Hickey WF,Korngold R, et al. Multiple loci govern the bone marrow－derived immunoregulatory mechanism controlling dominant resistance to autoimmune orchitis[J]. Proceedings of the National Academy of Sciences of the United States of America, 1995, 92(12): 5684-5688.
|
| [26] |
Ono A,Ikeda E,Mochizuki M, et al. Provirus load in patients with human T－cell leukemia virus type 1 uveitis correlates with precedent Graves' disease and disease activities[J]. Jpn J Cancer Res, 1998, 89(6): 608-614.
|
| [27] |
Millánrodríguez AC,Fernándezcid C,Garcíacampello M, et al. Intermediate uveitis due to human T－cell lymphotropic virus type 1[J]. Archivos De La Sociedad Española De Oftalmología, 2012, 87(2): 44-46.
|
| [28] |
Merle H,Cabre P,Olindo S, et al. Ocular lesions in 200 patients infected by the human T－cell lymphotropic virus type 1 in martinique (French West Indies)[J]. Am J Ophthalmol, 2002, 134(2): 190-195.
|
| [29] |
Takahashi T,Takase H,Urano T, et al. Clinical features of human T－lymphotropic virus type 1 uveitis: a long－term follow－up[J]. Ocular Immunology & Inflammation, 2000, 8(4): 235-241.
|
| [30] |
Yukawa E,Urano T,Nakahara M, et al. Pattern－reversal visual evoked potentials in patients with human T－lymphotropic virus type 1 uveitis[J]. Current Eye Research, 2006, 31(1): 37-42.
|
| [31] |
Yoshimura K,Mochizuki M,Araki S, et al. Clinical and Immunologic Features of Human T－cell Lymphotropic Virus Type Ⅰ Uveitis[J]. Am J Ophthalmol, 1993, 116(2): 156-163.
|
| [32] |
Pinheiro SR,Martins－Filho OA,Ribas JG, et al. Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T－cell lymphotropic virus type 1[J]. Am J Ophthalmol, 2006, 142(5): 811-815.
|
| [33] |
Ohba N,Nakao K,Isashiki Y, et al. Clinical features of HTLV－Ⅰ associated uveitis determined in multicenter collaborative study. Study Group for HTLV－Ⅰ Associated Ocular Diseases.[J]. Japanese Journal of Ophthalmology, 1994, 38(2): 168-174.
|
| [34] |
Cohen DB,Glasgow BJ. Bilateral optic nerve cryptococcosis in sudden blindness in patients with acquired immune deficiency syndrome[J]. Ophthalmology, 1993, 100(11): 1689-1694.
|
| [35] |
Denning DW,Armstrong RW,Lewis BH, et al. Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome[J]. American Journal of Medicine, 1991, 91(3): 267-272.
|
| [36] |
Maruki C,Nakano H,Shimoji T, et al. Loss of vision due to cryptococcal optochiasmatic arachnoiditis and optocurative surgical exploration－case report[J]. Neurologia medico－chirurgica, 1988, 28(7): 695-697.
|
| [37] |
Takeda A,Ishibashi T,Sonoda KH. Epidemiology of Uveitis , Caused by HTLV－1 , Toxoplasmosis , and Tuberculosis ; the Three Leading Causes of Endemic Infectious Uveitis in Japan[J]. Ocul Immunol Inflamm , 2016 , 7(6): 1-5.
|
| [38] |
Pinheiro SR,Carneiroproietti AB,Limamartins MV, et al. HTLV－Ⅰ/Ⅱ seroprevalence in 55 Brazilian patients with idiopathic uveitis[J]. Revista Da Sociedade Brasileira De Medicina Tropical, 1996, 29(4): 383-384.
|
| [39] |
Sakurai T,Yukawa E,Hara Y, et al. Indocyanine green angiography in patients with human T cell－lymphotropic virus type 1 uveitis[J]. Graefes Arch Clin Exp Ophthalmol , 2002 , 240(2): 101-105.
|
| [40] |
Proietti FA,Carneiro－Proietti ABF,Catalan－Soares BC, et al. Global epidemiology of HTLV－Ⅰ infection and associated diseases[J]. Oncogene, 2005, 24(39): 6058-6068.
|
| [41] |
Oniki T,Murata T,Sakamoto T, et al. A Case of Human T Lymphotropic Virus Type Ⅰ－associated Uveitis with Cystoid Macular Edema[J]. Folia ophthalmologica Japonica , 1995 , 46(11) : 1196-1199.
|
| [42] |
Munk MR,Kiss CG,Steiner I, et al. Systematic correlation of morphologic alterations and retinal function in eyes with uveitis－associated cystoid macular oedema during development, resolution and relapse[J]. British Journal of Ophthalmology, 2013, 97(10): 1289-1296.
|
| [43] |
Liu MM,Furusato E,Cao X, et al. Ocular manifestations and pathology of adult T－cell leukemia/lymphoma associated with human T－lymphotropic virus type 1[J]. Rare Tumors, 2010, 2(4): e63.
|
| [44] |
Warwar RE,Bullock JD,Ballal D. Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients[J]. Ophthalmology, 1998, 105(2): 263-268.
|
| [45] |
Alm A,Stjernschantz J. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group[J]. Ophthalmology, 1995, 102(12): 1743-1752.
|
| [46] |
Ziai N,Dolan JW,Kacere RD, et al. The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes[J]. Archives of Ophthalmology, 1993, 111(10): 1351-1358.
|
| [47] |
Watson P,Stjernschantz J. A six－month, randomized, double－masked study comparing latanoprost with timolol in open－angle glaucoma and ocular hypertension. The Latanoprost Study Group[J]. Ophthalmology, 1996, 103(1): 126-137.
|
| [48] |
Flach AJ,Jampol LM,Weinberg D, et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine[J]. American Journal of Ophthalmology, 1991, 112(5): 514-519.
|
| [49] |
Alm A,Villumsen J. PhXA34, a new potent ocular hypotensive drug. A study on dose－response relationship and on aqueous humor dynamics in healthy volunteers[J]. Archives of Ophthalmology, 1991, 109(11): 1564-1568.
|
| [50] |
Bito LZ,Stjernschantz J,Resul B, et al. The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41 (latanoprost), for glaucoma management[J]. Journal of Lipid Mediators, 1993, 6(3): 535-543.
|
| [51] |
Jaffe GJ,Martin D,Callanan D, et al. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty－four－week results of a multicenter randomized clinical study[J]. Ophthalmology, 2006, 113(6): 1020-1028.
|
| [52] |
Aung T,Chew PT,Yip CC, et al. A randomized double－masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open－angle glaucoma and ocular hypertension[J]. Am J Ophthalmol, 2001, 131(5): 636-642.
|
| [53] |
Nakao K,Ohba N,Nakagawa M, et al. Clinical course of HTLV－Ⅰ－associated uveitis[J]. Japanese Journal of Ophthalmology, 1999, 43(5): 404-409.
|
| [54] |
Kawai H,Mitsui T,Yokoi K, et al. Evidence of HTLV－Ⅰ in thyroid tissue in an HTLV－Ⅰ carrier with Hashimoto's thyroiditis[J]. Journal of Molecular Medicine, 1996, 74(5): 275-278.
|
| [55] |
Tamiya S,Matsuoka M,Takemoto S, et al. Adult T cell leukemia following HTLV－Ⅰ－associated myelopathy/tropical spastic paraparesis: case reports and implication to the natural course of ATL[J]. Leukemia, 1995, 9(10): 1768-1770.
|
| [56] |
Leons FE,Costa CM,Gaffga N. Discrepancy, coincidence or evidence in chronic idiopathic spastic paraparesis throughout the world. A meta－analysis on 2811 patients[J]. Arquivos de neuro－psiquiatria, 1997, 55(3): 530-535.
|
| [57] |
Listed N. Mantakassa: an epidemic of spastic paraparesis associated with chronic cyanide intoxication in a cassava staple area of Mozambique. 2. Nutritional factors and hydrocyanic acid content of cassava products. Ministry of Health, Mozambique[J]. Bulletin of the World Health Organization, 1984, 62(3): 485-492.
|
| [58] |
Listed N. Mantakassa: an epidemic of spastic paraparesis associated with chronic cyanide intoxication in a cassava staple area of Mozambique. 1. Epidemiology and clinical and laboratory findings in patients. Ministry of Health, Mozambique[J]. Bulletin of the World Health Organization, 1984, 62(3): 477-484.
|
| [59] |
Mead SH,Proukakis C,Wood N, et al. A large family with hereditary spastic paraparesis due to a frame shift mutation of the spastin (SPG4) gene: association with multiple sclerosis in two affected siblings and epilepsy in other affected family members[J]. Journal of Neurology Neurosurgery & Psychiatry, 2001, 71(6): 788-791.
|
| [60] |
Hino S,Katamine S,Miyata H, et al. Primary prevention of HTLV－1 in Japan[J]. Leukemia, 1997, 11 (Suppl. 1): 57-59.
|
| [61] |
Iwanaga M,Chiyoda S,Kusaba E, et al. Trends in the seroprevalence of HTLV－1 in Japanese blood donors in Nagasaki Prefecture, 2000－2006[J]. International Journal of Hematology, 2009, 90(2): 186-190.
|
| [62] |
Stuver SO,Tachibana N,Okayama A, et al. Determinants of HTLV－1 seroprevalence in Miyazaki Prefecture, Japan: a cross－sectional study[J]. Journal of Acquired Immune Deficiency Syndromes, 1992, 5(1): 12-18.
|
| [63] |
Watanabe T,Iwasaki Y,Tashiro K, et al. No Evidence of HTLV－1 Infection in Japanese Multiple Sclerosis Patients in Polymerase Chain Reaction[J]. Jpn J Cancer Res, 2010, 80(11): 1017-1020.
|
| [64] |
Bandeira LM,Uehara SN,Asato MA, et al. High Prevalence of HTLV－1 Infection among Japanese Immigrants in Non－endemic Area of Brazil[J]. Plos Neglected Tropical Diseases, 2015, 9(4): e0003691.
|
| [65] |
Otani M,Honda N,Xia PC, et al. Distribution of Two Subgroups of Human T－Lymphotropic Virus Type 1 (HTLV－1) in Endemic Japan[J]. Tropical Medicine & Health, 2012, 40(2): 55-58.
|
| [66] |
Nakamura T. HTLV－Ⅰ－associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV－Ⅰ－infected Th1 cells in the pathogenesis, and therapeutic strategy[J]. Folia Neuropathologica, 2009, 47(2): 182-194.
|
| [67] |
Nagai M,Utsunomiya T,Takenouchi N, et al. Failure to detect HTLV type 1 DNA from HTLV type 1－seronegative patients with chronic progressive spastic paraparesis in Kagoshima[J]. Aids Research & Human Retroviruses, 2002, 18(14): 1089-1090.
|
| [68] |
Poiesz BJ,Ruscetti FW,Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T－cell lymphoma[J]. Proceedings of the National Academy of Sciences of the United States of America, 1980, 77(12): 7415-7419.
|
| [69] |
Nose H,Saito M,Usuku K, et al. Clinical symptoms and the odds of human T－cell lymphotropic virus type 1－associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: Application of best－fit logistic regression equation based on host genotype, age, and provirus[J]. Journal of Neurovirology, 2006, 12(3): 171-177.
|
| [70] |
Link H,Tibbling G. Principles of albumin and IgG analyses in neurological disorders.Ⅲ. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis[J]. Scandinavian Journal of Clinical & Laboratory Investigation, 1977, 37(5): 397-401.
|
| [71] |
Schönbach C,Nokihara K,Bangham CR, et al. Identification of HTLV－1－Specific CTL Directed against Synthetic and Naturally Processed Peptides in HLA－B*3501 Transgenic Mice[J]. Virology, 1996, 226(1): 102-112.
|
| [72] |
Albietz JM,McLennan SG,Lenton LM. Ocular surface management of photorefractive keratectomy and laser in situ keratomileusis[J]. American Journal of Ophthalmology, 1900, 19(6): 636-644.
|
| [73] |
Sauvageot P,Julio G,Alvarez d TJ, et al. Femtosecond laser－assisted laser in situ keratomileusis versus photorefractive keratectomy: Effect on ocular surface condition[J]. Journal of Cataract & Refractive Surgery, 2017, 43(2): 167-173.
|
| [74] |
Bower KS,Sia RK,Ryan DS, et al. Chronic dry eye in photorefractive keratectomy and laser in situ keratomileusis: Manifestations, incidence, and predictive factors[J]. J Cataract Refract Surg, 2015, 41(12): 2624-2634.
|
| [75] |
Pflugfelder SC,Tseng SC,Yoshino K, et al. Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation[J]. Ophthalmology, 1997, 104(2): 223-235.
|